Neurostimulation
Navigation Links
Neurostimulation in Medical News
Driven by technology advancements, rising consumer awareness, and development of sophisticated implantable neurostimulation devices, world market for neurostimulation is projected to reach $5.2 billion by the year 2012. Conducive demographics like the aging world population offers ample opportuni...
...ze long-term results for the patients." "The physiologic mechanisms associated with OSA lend themselves well to the application of the advanced neurostimulation and sensing technology provided by the Inspire system," added Dr. Glen Nelson, Chairman for Inspire Medical Systems. Dr. Nelson was formerly Vice-Chai...
Urgent(R) PC and Macroplastique(R) Featured in Numerous IUGA 2009 Sessions
...ons at the IUGA annual meeting included: "Peripheral Tibial neurostimulation (PTNS) (Urgent PC) Versus Tolterodine (Detrusitol) In the Treatment Of Wome...Urgent(R) PC system, which we believe is the only FDA-approved non-surgical neurostimulation therapy for the treatment of urinary symptoms often associated with overact...EaglePicher Medical Power Announces New Li/CFx Battery Technology
...CFx battery chemistry provides higher energy density for use in a variety of implantable applications including telemetry-capable pacemakers and ICDs, neurostimulation devices, drug pumps, body fluid pumps and monitors. Benefits include: Proprietary ERI/EOL indicator for safe and predictable r...Unique nerve-stimulation device proves effective against epilepsy
... implanted above the eyebrow that would stimulate the trigeminal nerve and replace the external device. "TNS is a promising alternative mode of neurostimulation because the trigeminal nerve can be stimulated in minimally invasive fashion," DeGiorgio said. "The major branches of the trigeminal nerve in the face...JumpStart and Case Technology Ventures Invest in Neuros Medical
...al, Inc. , a Cleveland, OH company commercializing neurostimulation technology developed at Case Western Reserve Univ...in a much higher frequency range than conventional neurostimulation devices, Neuros' technology is able to stop nerve ...her stakeholders including the FES Center and Ohio neurostimulation Neuromodulation Partnership and its regional for-p......ze long-term results for the patients." "The physiologic mechanisms associated with OSA lend themselves well to the application of the advanced neurostimulation and sensing technology provided by the Inspire system," added Dr. Glen Nelson, Chairman for Inspire Medical Systems. Dr. Nelson was formerly Vice-Chai...
Arizona Technology Enterprises (AzTE) Hosts the ASU Tech Forum for the Investment Community
...nvestment opportunities relate to biofuels and biomaterials derived from photosynthetic organisms, DNA and protein sequencing and detection platforms, neurostimulation technologies, sensor technologies, synthetic antibodies, advanced battery technologies, LED substrates, and low-power design methodology. In addi...Medicare to Reimburse for the Bioness L300™ Foot Drop System for Spinal Cord Injury
...dividual's gait, increased range-of-motion and improved blood circulation that the NESS L300 may provide. The NESS L300 is the only adaptive, wireless neurostimulation device for foot drop offered in acute, in-patient and out-patient rehabilitation centers as well as for home use. "In the U.S. there are ap...Uroplasty to Highlight Urgent PC System at American Urological Association 2008 Annual Meeting
...nt of voiding dysfunctions. Our primary focus is the commercialization of our Urgent PC system, which we believe is the only FDA-approved non-surgical neurostimulation therapy for the treatment of urinary symptoms often associated with overactive bladder (OAB). We also offer Macroplastique(R) Implants, a urethral bul...Uroplasty Plans to Double Sales Force During Fiscal 2009
...nt of voiding dysfunctions. Our primary focus is the commercialization of our Urgent PC system, which we believe is the only FDA-approved non-surgical neurostimulation therapy for the treatment of overactive bladder (OAB) symptoms. We also offer Macroplastique(R) Implants, a bulking agent for the treatment of urinary...Neurostimulation in Medical Technology
...ology platforms resolve a number of respiratory clinical needs and
create a neurostimulation market segment for these treatments. Clinical
studies and research for othe...002, Synapse Biomedical's mission is to commercialize our
life-transforming neurostimulation platform used to treat people with
respiratory insufficiency. Synapse is ba...
Uroplasty Highlights Clinical Results From a Study of the Urgent(R) PC Neuromodulation System
...nt of voiding dysfunctions. Our primary focus is the commercialization of our Urgent PC system, which we believe is the only FDA-approved non-surgical neurostimulation therapy for the treatment of urinary urgency, urinary frequency and urge incontinence, symptoms often associated with a diagnosis of overactive bladde...New Study Supports Efficacy of Vagus Nerve Stimulation for Treatment-Resistant Depression
...de the most comprehensive collection of research being conducted in this emerging field. As editor-in-chief, George's extensive experience researching neurostimulation applications will aide him in facilitating and shaping the field's promising future. About MUSC Founded in 1824 in Charleston, The Medical Universit...Neurostimulation in Medical Products
RestorePRIME Neurostimulation System
Description: RESTOREPRIME is the First and Only 16-Electrode Non-Rechargeable Neurostimulator. Medtronic combined the powerful technology of RESTORE with the convenience of a non-rechargeable neurostimulator to create the unrivaled RESTOREPRIME. The ultimate non-rechargeable device, RESTOREPRIME offers ...Company:Medtronic Neurological and Spinal
Rapid Programmer 3.0 Neurostimulation Programming Platform
Description: The Rapid Programmer 3.0 is the smallest and lightest-weight clinician programming platform in the industry. It enables clinicians to quickly and efficiently test patients intraoperatively and to create programs for them postoperatively....Company:Advanced Neuromodulation Systems, Inc.
SynergyPlus™ Neurostimulation System
Description: The SynergyPlus+ is recommended for people with low to moderate pain in one or more limbs associated with failed back syndrome, low back or failed back. This may include people with post laminectomy pain, multiple back operations, unsuccessful disc surgery or degenerative disc disease and Complex R...Company:Medtronic Inc.
InterStim Therapy -- Sacral Nerve Stimulation (SNS) for Urinary Control
Description:...ts who have failed or could not tolerate more conservative treatments. Medtronic developed InterStim Therapy using more than 13 years of experience in neurostimulation therapies. The implantable InterStim System uses mild electrical stimulation of the sacral nerve that influences the behavior of the bladder, sphincte...Company:Medtronic Urology/Urogynecology
Neurostimulation in Biological News
Ultrasound shown to exert remote control of brain circuits
...er ultrasound can be harnessed for the noninvasive neurostimulation of brain circuits and offers the potential for new...plains. The search for new types of noninvasive neurostimulation methods led them to revisit ultrasound. "We we...nd engineers have also been rapidly developing new neurostimulation methods for controlling nervous system activity an...Neurostimulation in Biological Technology
Victhom announces completion of joint venture agreement with Otto Bock for Neurobionix activities
...nix division focuses on the development and commercialization of technologies and products involving implantable devices that feature neurosensing and neurostimulation components, integrated with artificial intelligence. Victhom's Biotronix division develops biomechatronic products to support or replace peripheral li......engthen our research and development activities in neurostimulation over the long term. As a growing global medical te... implantable devices that feature neurosensing and neurostimulation components, integrated with artificial intelligenc...ompany has a global infrastructure in the field of neurostimulation and offers sales, services and medical consulting....
...nix division focuses on the development and commercialization of technologies and products involving implantable devices that feature neurosensing and neurostimulation components, integrated with artificial intelligence. Victhom's Biotronix division develops biomechatronic products to support or replace peripheral li...
...nix division focuses on the development and commercialization of technologies and products involving implantable devices that feature neurosensing and neurostimulation components, integrated with artificial intelligence. Victhom's Biotronix division develops biomechatronic products to support or replace peripheral li...
...nix division focuses on the development and commercialization of technologies and products involving implantable devices that feature neurosensing and neurostimulation components, integrated with artificial intelligence. Victhom's Biotronix division develops biomechatronic products to support or replace peripheral li...
Victhom announces the completion of the second phase of the apnea therapy development
...her form of sensing can be as effective". Once apneas are detected, novel neurostimulation therapies can be used to restore breathing to patients in a very short time...es and products involving implantable devices that feature neurosensing and neurostimulation components, integrated with artificial intelligence. Victhom's Biotronix di...Victhom Announces Launch of Enhanced Company Website
...s; Neurobionix, which is developing an implantable neurostimulation device for gait disorders, and Biotronix, which is...foot drop sufferers as well as the emerging use of neurostimulation devices that provide instantaneous assistance to p... implantable devices that feature neurosensing and neurostimulation components, integrated with artificial intelligenc...Victhom to Participate in the OneMedPlace Finance Forum
...nix division focuses on the development and commercialization of technologies and products involving implantable devices that feature neurosensing and neurostimulation components, integrated with artificial intelligence. Victhom's Biotronix division develops biomechatronic products to support or replace peripheral li......usiness unit focuses on the development and commercialization of technologies and products involving implantable devices that feature neurosensing and neurostimulation components, integrated with artificial intelligence. Victhom's Biotronix business unit develops biomechatronic products to support or replace peripher...
Uroplasty Reports Record Sales for Third Fiscal Quarter and Nine Months Ended December 31, 2007
...nt of voiding dysfunctions. Our primary focus is the commercialization of our Urgent PC system, which we believe is the only FDA-approved non-surgical neurostimulation therapy for the treatment of overactive bladder (OAB) symptoms. We also offer Macroplastique(R) Implants, a bulking agent for the treatment of urinary...Other TagsFestivalOther Contentshomozygoushomozygoushomozygoushomozygoushorizontalhorizontalhorizontalhorizontalhorizontalhorizontalhorizontalhormoneshormoneshormoneshormoneshormoneshormoneshormoneshormoneshosthosthosthosthosthosthosthosthostinitiativeinitiativeinitiativeinitiativehybridhybridhybridhybridhybridhybridhybridhybrid
megawattsjournalismPostalorderingFestivalSachsPermanenteNavteqEskersutilizeDatasystgreetingdotcomRevisiting
(Date:12/1/2009)...TRIANGLE PARK, N.C., Dec. 1 Max Ne...have expanded over the years serving the top most ...ich was originally set up in an area of 2000 sq. f...part of the suite of services by Max Neeman, are r...ble offering. ,, The pharmacy inventory managem...
(Date:12/1/2009)... Dec. 1 Individuals in ...ly than those with traditional coverage to exhibit...engaged in wellness programs, and to be more incli...olding down costs, according to survey results rel...search Institute (EBRI). ,, At the same time, ...
(Date:12/1/2009)...RDALE, Fla., Dec. 1 OrbusNeich tod...in the randomized clinical trial of the Combo Bio-...,, A prospective, randomized, multicenter study...u M inal sirolimus coat ED bio- E ngineered...ites in Asia, Australia, Europe and South America ...
(Date:12/1/2009)...California are unable to successfully obtain infor... despite recent state legislation intended to impr..., Posing as low-income uninsured patients, resea...-third of the hospitals they approached and the es... allowed under California law, according to the fi...
(Date:12/1/2009)... Lumension announces general availability of its ...ver end-to-end endpoint management capabilities on...nt console architecture. , ...sion, a global leader in endpoint management and s...dpoint Management and Security Suite (LEMSS) tha...
Breaking Medicine News(10 mins):Health News:New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs 2Health News:New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs 3Health News:New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs 4Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 2Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 3Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 4Health News:Hospital price transparancy laws in California fall short, study finds 2Health News:New Lumension Endpoint Management and Security Suite To Deliver End-to-End Endpoint Management Capabilities 2Health News:New Lumension Endpoint Management and Security Suite To Deliver End-to-End Endpoint Management Capabilities 3Health News:New Lumension Endpoint Management and Security Suite To Deliver End-to-End Endpoint Management Capabilities 4Health News:New Lumension Endpoint Management and Security Suite To Deliver End-to-End Endpoint Management Capabilities 5Health News:New Lumension Endpoint Management and Security Suite To Deliver End-to-End Endpoint Management Capabilities 6[0] Max Neeman International Expands Its Pharmacy Services Facility In Delhi[0] New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs[0] OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent[0] Hospital price transparancy laws in California fall short, study finds[0] New Lumension Endpoint Management and Security Suite To Deliver End-to-End Endpoint Management Capabilities
(Date:12/1/2009)...nology has been awarded a U.S. Air Force Center of...rvesting and adaptive materials, and to develop to...e modern warfighter. , The $10.5 million Center...Nanostructures and Improved Cognition (BIONIC) cen...Sandhage, professors in Georgia Tech,s School of M...
(Date:12/1/2009)...m the United States, the other from Canada, put th...lf pack, on remote Ellesmere Island, only 600 mile... out what these "North Pole wolves" do in the long... of the world., "We first encountered 9-year-old... U.S. Geological Survey (USGS) wolf researcher who...
(Date:12/1/2009)...RNewswire/ -- iQor, a global provider of business ...n the 2009 InfoWorld 100 Awards Top 100 IT proje...eQ21. This was the first submission for iQor. ,...tigious list of companies," said Vikas Kapoor, pre...forming the way we do business, allowing us to wor...
Breaking Biology News(10 mins):Air Force Center of Excellence awarded in nanostructures and improved cognition 2Air Force Center of Excellence awarded in nanostructures and improved cognition 3Air Force Center of Excellence awarded in nanostructures and improved cognition 4North Pole wolf emails locations to researchers 2North Pole wolf emails locations to researchers 3iQor Named to InfoWorld 100 List of Top IT Projects of 2009 2Family Friends Influence Breast Cancer Decisions 56172 1Family Friends Influence Breast Cancer Decisions 56172 2Americas No 1 Pharmacy Names Great Health as Its Exclusive Health and Wellness Magazine 56168 1Saddle Ranch Productions Announces New Releases 56165 1Saddle Ranch Productions Announces New Releases 56165 2| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |